谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract 2242: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor Dinaciclib (SCH 727965) in patients with non-small cell lung cancer (NSCLC)

Martin J Edelman,Rajat Bannerji,Mark Navarro,Siulong Yao,Paul Statkevich,John Nemunaitis,Yingming Jou,Stephen L Warren,Benoit Samson,Anil A Joy,Da Zhang,J Stephenson

Cancer Research（2011）

引用 2|浏览14
暂无评分
关键词
cell lung cancer,lung cancer,inhibitor dinaciclib,cyclin-dependent,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要